Takeda to Highlight Ixazomib Clinical Development Program at Upcoming International Myeloma Workshop

Takeda Pharmaceutical Company Limited on September 22, 2015 announced that it will highlight the ixazomib clinical development program during multiple poster sessions at the upcoming 15th International Myeloma Workshop (IMW 2015) to be held in Rome, Italy, from September 23 to 26, 2015.
Source: International Myeloma Foundation - Category: Hematology Source Type: news